These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2219962)

  • 1. Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor.
    Grislain L; Mocquard MT; Dabe JF; Bertrand M; Luijten W; Marchand B; Resplandy G; Devissaguet M
    Xenobiotica; 1990 Aug; 20(8):787-800. PubMed ID: 2219962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
    Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
    Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation studies of di-acid angiotensin converting enzyme inhibitors.
    Drummer OH; Kourtis S
    Arzneimittelforschung; 1987 Nov; 37(11):1225-8. PubMed ID: 2964241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of perindopril on angiotensin converting enzyme in tissues of the rat.
    Jackson B; Cubela RB; Johnston CI
    J Hypertens Suppl; 1988 Dec; 6(3):S51-4. PubMed ID: 2852236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 5th communication: isolation and identification of metabolites of imidapril in rats, dogs, and monkeys.
    Yamada Y; Ohashi R; Sugawara Y; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):490-8. PubMed ID: 1642672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity binding sites for Perindopril a new inhibitor of angiotensin-I-converting enzyme (ACE) in the rabbit kidney: possible evidence for localization of ACE in endothelial structures and in glomerular mesangium.
    Morin JP; Moulin B; Borghi H; Fillastre JP
    Int J Tissue React; 1989; 11(2):81-92. PubMed ID: 2559047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Symposium on future prospects of angiotensin converting enzyme. Presentation of perindopril, a new and potent ACE inhibitor. Perindopril exerts an efficacious and rapid inhibition of ACE in plasma as well as in tissues].
    Med Clin (Barc); 1991 Apr; 96(16):suppl 2 p.. PubMed ID: 2051826
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and ACE inhibitory activity of the stereoisomers of perindopril (S 9490) and perindoprilate (S 9780).
    Vincent M; Marchand B; Rémond G; Jaguelin-Guinamant S; Damien G; Portevin B; Baumal JY; Volland JP; Bouchet JP; Lambert PH
    Drug Des Discov; 1992; 9(1):11-28. PubMed ID: 1457697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and metabolism of the angiotensin-converting enzyme inhibitor [4S-[4 alpha, 7 alpha, (R*), 12b beta]]-7-[S-(1-ethoxycarbonyl-3- phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo- pyrido[2,1-a][2]benzazepine-4-carboxylic acid in monkeys and dogs.
    Cheng H; Stuhler JD; Dorrbecker BR; Gordon WP
    Drug Metab Dispos; 1991; 19(1):212-7. PubMed ID: 1673401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
    Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
    Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
    Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
    Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive effect of perindopril. Experimental pharmacology].
    Barthelmebs M; Devissaguet M; Imbs JL
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():17-24. PubMed ID: 2505709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
    Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physiological disposition and metabolism of enalapril maleate in laboratory animals.
    Tocco DJ; deLuna FA; Duncan AE; Vassil TC; Ulm EH
    Drug Metab Dispos; 1982; 10(1):15-9. PubMed ID: 6124377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation studies of di-acid angiotensin converting enzyme inhibitors.
    Drummer OH; Kourtis S; Iakovidis D
    Arzneimittelforschung; 1988 May; 38(5):647-50. PubMed ID: 3415707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.